<DOC>
	<DOCNO>NCT02554292</DOCNO>
	<brief_summary>The main objective SeQuent® Please Neo post market surveillance assess clinical suitability combination pre-dilatation use NSE Alpha score balloon use paclitaxel-coated SeQuent® Please Neo 'all comer'/ 'real world ' set treatment in-stent restenosis .</brief_summary>
	<brief_title>Post Market Surveillance SeQuent Please Neo With Scoring Balloon</brief_title>
	<detailed_description>The aim post market surveillance document safety efficacy drug-coated balloon Sequent® Please Neo combination NSE Alpha score balloon treatment in-stent restenosis follow coronary stent implantation native coronary artery reference diameter 2.5 mm 4.0 mm lesion length 30 mm procedural success preservation vessel patency</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>patient instent restenosis coronary artery Intolerance paclitaxel and/or balloon coat Allergy component balloon coat Pregnancy lactation Complete occlusion treatment vessel Severely calcified stenosis Cardiogenic shock Risk intraluminal thrombus Haemorrhagic diathesis another disorder gastrointestinal ulceration cerebral circulatory disorder restrict use platelet aggregation inhibitor therapy anticoagulation therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>